Clinical course of high-grade glioma patients with a "biopsy-only" surgical approach: A need for individualised treatment

Clinical and Translational Oncology

Volumn 9, Issue 12, 2007, Pages 797-803

  Balana C ^a   Capellades, J ^b   Teixidor, P ^b   Roussos, I ^b   Ballester, R ^a   Cuello, M ^a   Arellano, A ^a   Florensa, R ^b   Rosell, R ^a  

^a CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^b HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

Author keywords

Biopsy; High grade gliomas

Indexed keywords

CARMUSTINE; CISPLATIN; LOMUSTINE; PROCARBAZINE; TEMOZOLOMIDE; VINCRISTINE;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BASAL GANGLION; CANCER ADJUVANT THERAPY; CANCER DIAGNOSIS; CANCER GRADING; CANCER INVASION; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; CORPUS CALLOSUM; DISEASE COURSE; FEMALE; GLIOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; KARNOFSKY PERFORMANCE STATUS; MAJOR CLINICAL STUDY; MALE; MOTOR CORTEX; MULTIPLE CANCER; OVERALL SURVIVAL; POSTOPERATIVE PERIOD; RETROSPECTIVE STUDY; SURGICAL MORTALITY; SURVIVAL TIME; TUMOR BIOPSY; TUMOR LOCALIZATION; VISUAL CORTEX; BIOPSY; BRAIN TUMOR; MIDDLE AGED; PATHOLOGY; SURVIVAL RATE;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY; BRAIN NEOPLASMS; FEMALE; GLIOMA; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 39149095000     PISSN: 1699048X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12094-007-0142-0     Document Type: Article

References (25)

1. Quigley MR, Maroon JC (1991) The relationship between survival and the extent of the resection in patients with supratentorial malignant gliomas. Neurosurgery 29:385-388; discussion 388-389
2. Metcalfe SE, Grant R (2000) Biopsy versus resection for malignant glioma. Cochrane Database Syst Rev CD002034
3. Proescholdt MA, Macher C, Woertgen C et al (2005) Level of evidence in the literature concerning brain tumour resection. Clin Neurol Neurosurg 107:95-98
4. Stupp R, Mason WP, van den Bent MJ et al (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987-996
5. Laws ER, Parney IF, Huang W et al (2003) Survival following surgery and prognostic factors for recently diagnosed malignant glioma: Data from the Glioma Outcomes Project. J Neurosurg 99:467-473
6. Kyritsis AP, Levin VA, Yung WK et al (1993) Imaging patterns of multifocal gliomas. Eur J Radiol 16:163-170
7. Kleihues P, Louis DN, Scheithauer BW et al (2002) The WHO classification of tumours of the nervous system. J Neuropathol Exp Neurol 61:215-225; discussion 226-219
8. Ammirati M, Vick N, Liao YL et al (1987) Effect of the extent of surgical resection on survival and quality of life in patients with supratentorial glioblastomas and anaplastic astrocytomas. Neurosurgery 21:201-206
9. Jeremic B, Grujicic D, Antunovic V et al (1994) Influence of extent of surgery and tumour location on treatment outcome of patients with glioblastoma multiforme treated with combined modality approach. J Neurooncol 21:177-185
10. Shinoda J, Sakai N, Murase S et al (2001) Selection of eligible patients with supratentorial glioblastoma multiforme for gross total resection. J Neurooncol 52:161-171
11. Lacroix M, Abi-Said D, Fourney DR et al (2001) A multivariate analysis of 416 patients with glioblastoma multiforme: Prognosis, extent of resection, and survival. J Neurosurg 95:190-198
12. Keles GE, Anderson B, Berger MS (1999) The effect of extent of resection on time to tumour progression and survival in patients with glibolastoma multiforme of the cerebral hemisphere. Surg Neurol 52:371-379
13. Jackson RJ, Fuller GN, Abi-Said D et al (2001) Limitations of sterotactic biopsy in the initial management of gliomas. Neuro-oncol 3:193-200
14. Chang SM, Parney IF, Huang W et al (2005) Patterns of care for adults with newly diagnosed malignant glioma. JAMA 293:557-564
15. Vives KP, Piepmeier JM (1999) Complications and expected outcome of glioma surgery. J Neurooncol 42:289-302
16. Do V, Gebski V, Barton MB (2000) The effect of waiting for radiotherapy for grade III/IV gliomas. Radiother Oncol 57:131-136
17. Vecht CJ, Avezaat CJ, van Putten WL et al (1990) The influence of the extent of surgery on the neurological function and survival in malignant glioma. A retrospective analysis in 243 patients. J Neurol Neurosurg Psychiatry 53:466-471
18. Ampil FL, Nanda A, Willis BK et al (1998) Treatment in patients with glioblastoma multiforme and poor performance status: Is it worthwhile? Radiat Med 16:109-112
19. Prados MD, Scott CB, Rotman M et al (1998) Influence of bromodeoxyuridine radiosensitization on malignant glioma patient survival: A retrospective comparison of survival data from the Northern California Oncology Group (NCOG) and Radiation Therapy Oncology Group trials (RTOG) for glioblastoma multiforme and anaplastic astrocytoma. Int J Radiat Oncol Biol Phys 40:653-659
20. Hou LC, Veeravagu A, Hsu AR et al (2006) Recurrent glioblastoma multiforme: A review of natural history and management options. Neurosurg Focus 20:E5
21. Grossman SA, O'Neill A, Grunnet M et al (2003) Phase III study comparing three cycles of infusional carmustine and cisplatin followed by radiation therapy with radiation therapy and concurrent carmustine in patients with newly diagnosed supratentorial glioblastoma multiforme: Eastern Cooperative Oncology Group Trial 2394. J Clin Oncol 21:1485-1491
22. Balana C, Lopez-Pousa A, Berrocal A et al (2004) Phase II study of temozolomide and cis-platin as primary treatment prior to radiotherapy in newly diagnosed glioblastoma multiforme patients with measurable disease. A study of the Spanish Medical Neuro-Oncology Group (GENOM). J Neurooncol 70:359-369
23. Brada M, Ashley S, Dowe A et al (2005) Neoadjuvant phase II multicentre study of new agents in patients with malignant glioma after minimal surgery. Report of a cohort of 187 patients treated with temozolomide. Ann Oncol 16:942-949
24. Vredenburgh JJ, Desjardins A, Herndon JE 2nd et al (2007) Phase II trial of bevacizumab and irinotecan in recurrent malignant glioma. Clin Cancer Res 13:1253-1259
25. Laws ER, Shaffrey ME, Morris A et al (2003) Surgical management of intracranial gliomas - does radical resection improve outcome? Acta Neurochir Suppl 85:47-53